[go: up one dir, main page]

DE60029318T8 - Verwendung von in der mittleren oder späten follikulären phase verabreichten lh zur behandlung von anovulatorischen frauen - Google Patents

Verwendung von in der mittleren oder späten follikulären phase verabreichten lh zur behandlung von anovulatorischen frauen Download PDF

Info

Publication number
DE60029318T8
DE60029318T8 DE60029318T DE60029318T DE60029318T8 DE 60029318 T8 DE60029318 T8 DE 60029318T8 DE 60029318 T DE60029318 T DE 60029318T DE 60029318 T DE60029318 T DE 60029318T DE 60029318 T8 DE60029318 T8 DE 60029318T8
Authority
DE
Germany
Prior art keywords
treatment
medium
follicular phase
anovulatory women
late follicular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE60029318T
Other languages
English (en)
Other versions
DE60029318T3 (de
DE60029318T2 (de
DE60029318D1 (de
Inventor
Stephen Franks
Stephen Hillier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60029318(T8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of DE60029318D1 publication Critical patent/DE60029318D1/de
Publication of DE60029318T2 publication Critical patent/DE60029318T2/de
Publication of DE60029318T8 publication Critical patent/DE60029318T8/de
Publication of DE60029318T3 publication Critical patent/DE60029318T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60029318.1T 1999-05-07 2000-05-05 Gonadotrophine Expired - Lifetime DE60029318T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07
EP99303574 1999-05-07
PCT/GB2000/001745 WO2000067778A1 (en) 1999-05-07 2000-05-05 Gonadotrophins
EP00927534.8A EP1176976B2 (de) 1999-05-07 2000-05-05 Gonadotrophine

Publications (4)

Publication Number Publication Date
DE60029318D1 DE60029318D1 (de) 2006-08-24
DE60029318T2 DE60029318T2 (de) 2007-08-09
DE60029318T8 true DE60029318T8 (de) 2007-11-22
DE60029318T3 DE60029318T3 (de) 2016-03-10

Family

ID=8241371

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029318.1T Expired - Lifetime DE60029318T3 (de) 1999-05-07 2000-05-05 Gonadotrophine

Country Status (18)

Country Link
US (2) US7695721B1 (de)
EP (1) EP1176976B2 (de)
JP (1) JP4975215B2 (de)
CN (1) CN1352566A (de)
AR (1) AR023869A1 (de)
AT (1) ATE332705T1 (de)
AU (1) AU4592800A (de)
BR (1) BR0010709B1 (de)
CA (1) CA2372714A1 (de)
DE (1) DE60029318T3 (de)
DK (1) DK1176976T4 (de)
ES (1) ES2267531T5 (de)
HK (1) HK1045261A1 (de)
IL (2) IL146252A0 (de)
PT (1) PT1176976E (de)
SI (1) SI1176976T2 (de)
TW (1) TWI242440B (de)
WO (1) WO2000067778A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
KR20040032952A (ko) * 2001-09-12 2004-04-17 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 과배란 유도에서 ｈｃｇ와 ｌｈ의 용도
MXPA04002256A (es) * 2001-09-12 2004-07-23 Applied Research Systems Uso de gonadotropina corionica humana (gch) en hiperestimulacion ovarica controlada.
US7341989B2 (en) * 2001-09-12 2008-03-11 Laboratories Seronosa Use of LH in controlled ovarian hyperstimulation
CA2515297A1 (en) * 2003-02-07 2004-08-19 Ambros Valentin Huber Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
PL1638595T3 (pl) 2003-06-20 2013-06-28 Ares Trading Sa Liofilizowane formulacje FSH/LH
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
WO2012042381A1 (en) * 2010-09-29 2012-04-05 Ferring B.V. Composition for controlled ovarian stimulation
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
KR20140053991A (ko) 2011-07-18 2014-05-08 아츠 바이올로직스 에이/에스 장기간 작용하는 황체 형성 호르몬 (ｌｈ) 화합물
WO2014013491A1 (en) * 2012-07-18 2014-01-23 Mor Research Applications Ltd. Intrauterine device
WO2018080120A1 (en) * 2016-10-28 2018-05-03 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3d ultrasound images
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5356876A (en) 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
JP2002531414A (ja) * 1998-12-01 2002-09-24 アクゾ・ノベル・エヌ・ベー 卵胞発生の改善

Also Published As

Publication number Publication date
AU4592800A (en) 2000-11-21
JP2002544168A (ja) 2002-12-24
ATE332705T1 (de) 2006-08-15
ES2267531T3 (es) 2007-03-16
TWI242440B (en) 2005-11-01
BR0010709B1 (pt) 2011-11-29
BR0010709A (pt) 2002-06-04
WO2000067778A1 (en) 2000-11-16
DE60029318T3 (de) 2016-03-10
US7151083B2 (en) 2006-12-19
US7695721B1 (en) 2010-04-13
SI1176976T2 (sl) 2015-12-31
HK1045261A1 (zh) 2002-11-22
AR023869A1 (es) 2002-09-04
SI1176976T1 (sl) 2006-10-31
DK1176976T3 (da) 2006-11-13
US20040224895A1 (en) 2004-11-11
DE60029318T2 (de) 2007-08-09
IL146252A (en) 2010-06-30
CN1352566A (zh) 2002-06-05
JP4975215B2 (ja) 2012-07-11
DK1176976T4 (en) 2015-11-02
CA2372714A1 (en) 2000-11-16
PT1176976E (pt) 2006-11-30
ES2267531T5 (es) 2015-11-24
DE60029318D1 (de) 2006-08-24
EP1176976B1 (de) 2006-07-12
EP1176976B2 (de) 2015-10-21
IL146252A0 (en) 2002-07-25
EP1176976A1 (de) 2002-02-06

Similar Documents

Publication Publication Date Title
DE60029318D1 (de) Verwendung von in der mittlere oder späte follikuläre phase verabreichte lh zur behandlung von anovulatorischen frauen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE69926385D1 (de) Behandlung von geweben
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69827126D1 (de) Verwendung von hypothalamus-hemmfaktor zur behandlung von ischämischen herzstörungen
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60023816D1 (de) Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60133996D1 (de) Kosmetisches VERFAHREN ZUR BEHANDLUNG VON Celluliten
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
DE60112423D1 (de) Verwendung von substituierten distamycin-acryloylderivaten zur behandlung von tumoren die mit erhöhten glutathion-spiegeln zusammenhängen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8381 Inventor (new situation)

Inventor name: FRANKS, STEPHEN, LONDON, GB

Inventor name: HILLIER, STEPHEN, EDINBURGH, GB

8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH